What is the appropriate approach and symptomatic management for postoperative shivering (rigor) in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Approach and Symptomatic Management of Postoperative Shivering (Rigor)

For established postoperative shivering, immediately administer meperidine 25-50 mg IV, which stops shivering in nearly 100% of patients within 5 minutes and is the single most effective pharmacologic agent available. 1

Initial Assessment and Differential Diagnosis

When encountering a postoperative patient with shivering, rapidly assess the following:

  • Measure core temperature to differentiate hypothermic from normothermic shivering, as hypothermia is the most common cause but shivering occurs even in normothermic patients 1
  • Check for infection signs: temperature ≥38.0°C, wound appearance, respiratory status, IV site phlebitis, and symptoms of sepsis 1
  • Assess pain control adequacy, as inadequate analgesia on postoperative day 2 can manifest as shivering 1
  • Distinguish from seizure: shivering presents as bilateral, symmetric, rhythmic oscillatory movements that respond to warming and anti-shivering medications, whereas seizures show asymmetric, asynchronous movements that do not respond to these measures 2

Immediate Non-Pharmacologic Interventions

Start these measures while preparing pharmacologic treatment:

  • Apply forced-air warming devices to actively warm the patient 1
  • Warm the extremities (surface counterwarming), which reduces the shivering threshold by approximately 4°C per degree of mean skin temperature increase 3
  • Administer warmed IV fluids if the patient is receiving fluid resuscitation 1, 3
  • Ensure adequate ambient room temperature 3

Pharmacologic Management Algorithm

First-Line Treatment: Meperidine

Meperidine 25-50 mg IV is the drug of choice, with the following evidence:

  • Stops shivering in nearly 100% of patients within 5 minutes 1, 3
  • Approximately 2,800 times more effective at inhibiting shivering than predicted by its analgesic potency alone 1, 3
  • Uniquely lowers the shivering threshold while directly suppressing shivering through mechanisms beyond analgesia 1, 3
  • Number-needed-to-treat (NNT) of 1.3 at 5 minutes and 1.5 at 10 minutes 4

Caution: Exercise care in patients at risk for seizures, as meperidine lowers the seizure threshold 1

Alternative Pharmacologic Options

If meperidine is contraindicated or unavailable, consider these alternatives in order of efficacy:

Second-Line Options:

  • Tramadol 35-220 mg IV: NNT of 2.2, with evidence of efficacy in prevention and treatment 5, 6
  • Nefopam 10-20 mg IV: NNT of 1.7, more effective than meperidine or clonidine in one neurosurgical study (95% vs 32% and 40% respectively) 6, 7
  • Clonidine 150 μg IV: NNT of 1.3 at 5 minutes, though associated with potential hemodynamic effects 4, 6
  • Doxapram 100 mg IV: NNT of 1.7 at 5 minutes 4

Adjunctive Agents (insufficient as monotherapy):

  • Magnesium sulfate 2-4 g bolus, then 1 g/h infusion: Safe adjunct but inadequate alone for clinically significant shivering; maintain serum levels <4 mg/dL 1, 3
  • Acetaminophen: Non-sedating adjunct but typically insufficient alone 3

Sedative/Analgesic Approach

For patients requiring deeper sedation or with refractory shivering:

  • Continuous opioid infusion (fentanyl or hydromorphone) at moderate doses 3
  • Add short-acting sedative (dexmedetomidine or propofol) titrated to minimum effective dose 3
  • Avoid propofol or dexmedetomidine as first-line in hemodynamically unstable patients due to hypotension risk 3

Last Resort: Neuromuscular Blockade

For refractory shivering unresponsive to pharmacologic measures:

  • Cisatracurium 0.1-0.2 mg/kg bolus, then 0.5-10 μg/kg/min infusion is the most effective abortive measure 3
  • Preferred due to non-enzymatic plasma degradation, making it safe in renal and hepatic impairment 3
  • Particularly appropriate when active temperature management is expected to be transient 1

Cause-Specific Management

Hypothermia-Related Shivering

  • Continue active warming with forced-air devices until normothermia achieved 1
  • Remember that delayed hypothermia can occur on postoperative day 2 due to heat redistribution from core to periphery 1

Pain-Related Shivering

  • Administer NSAIDs if not contraindicated 1
  • Ensure regular (not as-needed) pain medication administration 1

Infection-Related Shivering

  • Obtain blood cultures if temperature ≥38.0°C 1, 3
  • Initiate appropriate antibiotics if infection suspected 1
  • Provide supportive care including hydration and oxygenation 1
  • Rule out respiratory infections, wound infections, and phlebitis 1

Critical Pitfalls to Avoid

  • Do not rely on acetaminophen or magnesium alone for clinically significant shivering—these are adjuncts only 3
  • Do not delay meperidine administration while attempting less effective measures in symptomatic patients 1
  • Do not miss early infection, as temperature spikes with shivering may be the first sign requiring prompt evaluation 1
  • Do not use excessive sedation when simpler measures (meperidine + warming) are highly effective 1

Special Populations

  • Sickle cell disease patients: Require particular attention as shivering can precipitate sickling crisis 1
  • Neuraxial anesthesia patients: May experience delayed shivering on day 2 as the block wears off 1
  • Post-cardiac arrest or brain injury patients: Shivering doubles metabolic rate and nearly triples oxygen consumption, worsening secondary injury 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.